Almirall SA
MAD:ALM

Watchlist Manager
Almirall SA Logo
Almirall SA
MAD:ALM
Watchlist
Price: 8.47 EUR 2.11% Market Closed
Market Cap: 1.8B EUR
Have any thoughts about
Almirall SA?
Write Note

Relative Value

The Relative Value of one ALM stock under the Base Case scenario is 12.62 EUR. Compared to the current market price of 8.47 EUR, Almirall SA is Undervalued by 33%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

ALM Relative Value
Base Case
12.62 EUR
Undervaluation 33%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
87
vs Industry
62
Median 3Y
1.5
Median 5Y
1.5
Industry
2.5
Forward
1.8
vs History
vs Industry
0
Median 3Y
-53.6
Median 5Y
10.6
Industry
21.9
Forward
40
vs History
49
vs Industry
25
Median 3Y
11.9
Median 5Y
11.9
Industry
16.5
vs History
vs Industry
10
Median 3Y
-6.3
Median 5Y
9.2
Industry
23.6
vs History
74
vs Industry
53
Median 3Y
1.3
Median 5Y
1.4
Industry
2.1
vs History
96
vs Industry
61
Median 3Y
1.5
Median 5Y
1.7
Industry
2.6
Forward
1.8
vs History
96
vs Industry
70
Median 3Y
2.1
Median 5Y
2.3
Industry
5.2
vs History
44
vs Industry
27
Median 3Y
9.7
Median 5Y
9.2
Industry
13.3
Forward
9.7
vs History
26
vs Industry
3
Median 3Y
23.4
Median 5Y
19.6
Industry
16.6
Forward
27.8
vs History
53
vs Industry
25
Median 3Y
12.2
Median 5Y
12.1
Industry
15.6
vs History
vs Industry
8
Median 3Y
17.6
Median 5Y
18.3
Industry
19.1
vs History
87
vs Industry
58
Median 3Y
1
Median 5Y
1.1
Industry
1.9

Multiples Across Competitors

ALM Competitors Multiples
Almirall SA Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
ES
Almirall SA
MAD:ALM
1.8B EUR 1.3 -50.4 9.4 30.9
JP
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
776 550.9T JPY 4 211 733 -5 347 888.9 -5 459 134.4 -5 046 864.6
US
Eli Lilly and Co
NYSE:LLY
710.5B USD 17.4 84.9 45.7 51
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
DK
Novo Nordisk A/S
CSE:NOVO B
3.3T DKK 12.3 35 24.3 27.8
US
Johnson & Johnson
NYSE:JNJ
373.5B USD 4.3 25.4 12.3 16
US
Merck & Co Inc
NYSE:MRK
251.1B USD 4 20.7 10.5 12.5
CH
Roche Holding AG
SIX:ROG
202.7B CHF 3.5 17.6 9.9 11.8
CH
Novartis AG
SIX:NOVN
183.3B CHF 4.1 11.6 10.1 14
UK
AstraZeneca PLC
LSE:AZN
162.4B GBP 4.1 31.6 169.4 253.9
IE
Endo International PLC
LSE:0Y5F
146B USD 63 -49.9 234.4 587.7
P/E Multiple
Earnings Growth
ES
Almirall SA
MAD:ALM
Average P/E: 32.4
Negative Multiple: -50.4
N/A
JP
N
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
Negative Multiple: -5 347 888.9 N/A
US
Eli Lilly and Co
NYSE:LLY
84.9
451%
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A
DK
Novo Nordisk A/S
CSE:NOVO B
35
86%
US
Johnson & Johnson
NYSE:JNJ
25.4
-22%
US
Merck & Co Inc
NYSE:MRK
20.7
7 321%
CH
Roche Holding AG
SIX:ROG
17.6
32%
CH
Novartis AG
SIX:NOVN
11.6
21%
UK
AstraZeneca PLC
LSE:AZN
31.6
177%
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -49.9 N/A

See Also

Discover More
Back to Top